nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—SLCO3A1—Methotrexate—multiple sclerosis	0.335	0.765	CbGbCtD
Alprostadil—ABCC4—Methotrexate—multiple sclerosis	0.103	0.235	CbGbCtD
Alprostadil—Misoprostol—PTGER4—multiple sclerosis	0.0105	0.781	CrCbGaD
Alprostadil—PTGIR—brainstem—multiple sclerosis	0.00334	0.0621	CbGeAlD
Alprostadil—Dinoprostone—PTGER4—multiple sclerosis	0.00294	0.219	CrCbGaD
Alprostadil—SLCO3A1—retina—multiple sclerosis	0.00284	0.0529	CbGeAlD
Alprostadil—PTGER1—nervous system—multiple sclerosis	0.00283	0.0527	CbGeAlD
Alprostadil—PTGER1—central nervous system—multiple sclerosis	0.00273	0.0507	CbGeAlD
Alprostadil—ABCC5—retina—multiple sclerosis	0.00258	0.0479	CbGeAlD
Alprostadil—PTGIR—spinal cord—multiple sclerosis	0.00208	0.0386	CbGeAlD
Alprostadil—SLCO3A1—medulla oblongata—multiple sclerosis	0.00205	0.0382	CbGeAlD
Alprostadil—SLCO3A1—midbrain—multiple sclerosis	0.00188	0.0349	CbGeAlD
Alprostadil—ABCC5—medulla oblongata—multiple sclerosis	0.00186	0.0346	CbGeAlD
Alprostadil—SLCO3A1—spinal cord—multiple sclerosis	0.00183	0.0341	CbGeAlD
Alprostadil—PTGIR—nervous system—multiple sclerosis	0.00175	0.0325	CbGeAlD
Alprostadil—ABCC5—midbrain—multiple sclerosis	0.0017	0.0316	CbGeAlD
Alprostadil—PTGIR—central nervous system—multiple sclerosis	0.00168	0.0313	CbGeAlD
Alprostadil—PTGIR—cerebellum—multiple sclerosis	0.00165	0.0306	CbGeAlD
Alprostadil—SLCO3A1—nervous system—multiple sclerosis	0.00154	0.0287	CbGeAlD
Alprostadil—SLCO2A1—nervous system—multiple sclerosis	0.00153	0.0284	CbGeAlD
Alprostadil—SLCO3A1—central nervous system—multiple sclerosis	0.00149	0.0276	CbGeAlD
Alprostadil—SLCO2A1—central nervous system—multiple sclerosis	0.00147	0.0274	CbGeAlD
Alprostadil—SLCO2B1—medulla oblongata—multiple sclerosis	0.00146	0.0271	CbGeAlD
Alprostadil—SLCO3A1—cerebellum—multiple sclerosis	0.00145	0.027	CbGeAlD
Alprostadil—PTGIR—brain—multiple sclerosis	0.00134	0.0249	CbGeAlD
Alprostadil—ABCC5—cerebellum—multiple sclerosis	0.00132	0.0245	CbGeAlD
Alprostadil—SLCO2B1—spinal cord—multiple sclerosis	0.0013	0.0242	CbGeAlD
Alprostadil—SLCO3A1—brain—multiple sclerosis	0.00118	0.0219	CbGeAlD
Alprostadil—SLCO2A1—brain—multiple sclerosis	0.00117	0.0217	CbGeAlD
Alprostadil—SLCO2B1—nervous system—multiple sclerosis	0.00109	0.0204	CbGeAlD
Alprostadil—ABCC5—brain—multiple sclerosis	0.00107	0.0199	CbGeAlD
Alprostadil—SLCO2B1—central nervous system—multiple sclerosis	0.00105	0.0196	CbGeAlD
Alprostadil—SLCO2B1—cerebellum—multiple sclerosis	0.00103	0.0192	CbGeAlD
Alprostadil—ABCC4—nervous system—multiple sclerosis	0.000969	0.018	CbGeAlD
Alprostadil—ABCC4—central nervous system—multiple sclerosis	0.000933	0.0174	CbGeAlD
Alprostadil—SLCO2B1—brain—multiple sclerosis	0.000837	0.0156	CbGeAlD
Alprostadil—ABCC4—brain—multiple sclerosis	0.000741	0.0138	CbGeAlD
Alprostadil—Anaemia—Mitoxantrone—multiple sclerosis	0.000443	0.00175	CcSEcCtD
Alprostadil—Visual impairment—Prednisolone—multiple sclerosis	0.000435	0.00172	CcSEcCtD
Alprostadil—Hypokalaemia—Prednisone—multiple sclerosis	0.000431	0.00171	CcSEcCtD
Alprostadil—Asthenia—Cladribine—multiple sclerosis	0.000427	0.00169	CcSEcCtD
Alprostadil—Hyperglycaemia—Betamethasone—multiple sclerosis	0.000424	0.00168	CcSEcCtD
Alprostadil—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.000424	0.00168	CcSEcCtD
Alprostadil—Bradycardia—Triamcinolone—multiple sclerosis	0.000422	0.00167	CcSEcCtD
Alprostadil—Bradycardia—Methylprednisolone—multiple sclerosis	0.000421	0.00167	CcSEcCtD
Alprostadil—Pruritus—Cladribine—multiple sclerosis	0.000421	0.00166	CcSEcCtD
Alprostadil—Cough—Mitoxantrone—multiple sclerosis	0.000418	0.00165	CcSEcCtD
Alprostadil—Haemoglobin—Triamcinolone—multiple sclerosis	0.000417	0.00165	CcSEcCtD
Alprostadil—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000416	0.00164	CcSEcCtD
Alprostadil—Rhinitis—Triamcinolone—multiple sclerosis	0.000416	0.00164	CcSEcCtD
Alprostadil—Rhinitis—Methylprednisolone—multiple sclerosis	0.000415	0.00164	CcSEcCtD
Alprostadil—Haemorrhage—Triamcinolone—multiple sclerosis	0.000415	0.00164	CcSEcCtD
Alprostadil—Convulsion—Mitoxantrone—multiple sclerosis	0.000415	0.00164	CcSEcCtD
Alprostadil—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000414	0.00164	CcSEcCtD
Alprostadil—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.000413	0.00163	CcSEcCtD
Alprostadil—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.000413	0.00163	CcSEcCtD
Alprostadil—Hypertension—Mitoxantrone—multiple sclerosis	0.000413	0.00163	CcSEcCtD
Alprostadil—Pharyngitis—Triamcinolone—multiple sclerosis	0.000412	0.00163	CcSEcCtD
Alprostadil—Myocardial infarction—Dexamethasone—multiple sclerosis	0.000411	0.00163	CcSEcCtD
Alprostadil—Myocardial infarction—Betamethasone—multiple sclerosis	0.000411	0.00163	CcSEcCtD
Alprostadil—Diarrhoea—Cladribine—multiple sclerosis	0.000407	0.00161	CcSEcCtD
Alprostadil—Lethargy—Methotrexate—multiple sclerosis	0.000404	0.0016	CcSEcCtD
Alprostadil—Discomfort—Mitoxantrone—multiple sclerosis	0.000403	0.00159	CcSEcCtD
Alprostadil—Sweating increased—Prednisone—multiple sclerosis	0.000399	0.00158	CcSEcCtD
Alprostadil—Visual impairment—Methylprednisolone—multiple sclerosis	0.000399	0.00158	CcSEcCtD
Alprostadil—Feeling abnormal—Azathioprine—multiple sclerosis	0.000398	0.00157	CcSEcCtD
Alprostadil—Dizziness—Cladribine—multiple sclerosis	0.000393	0.00155	CcSEcCtD
Alprostadil—Erythema—Prednisolone—multiple sclerosis	0.000393	0.00155	CcSEcCtD
Alprostadil—Oedema—Mitoxantrone—multiple sclerosis	0.000391	0.00154	CcSEcCtD
Alprostadil—Infection—Mitoxantrone—multiple sclerosis	0.000388	0.00153	CcSEcCtD
Alprostadil—Shock—Mitoxantrone—multiple sclerosis	0.000384	0.00152	CcSEcCtD
Alprostadil—Bradycardia—Dexamethasone—multiple sclerosis	0.000383	0.00152	CcSEcCtD
Alprostadil—Bradycardia—Betamethasone—multiple sclerosis	0.000383	0.00152	CcSEcCtD
Alprostadil—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000383	0.00151	CcSEcCtD
Alprostadil—Abdominal pain—Azathioprine—multiple sclerosis	0.000382	0.00151	CcSEcCtD
Alprostadil—Body temperature increased—Azathioprine—multiple sclerosis	0.000382	0.00151	CcSEcCtD
Alprostadil—Tachycardia—Mitoxantrone—multiple sclerosis	0.000381	0.00151	CcSEcCtD
Alprostadil—Skin disorder—Mitoxantrone—multiple sclerosis	0.00038	0.0015	CcSEcCtD
Alprostadil—Haemoglobin—Betamethasone—multiple sclerosis	0.000378	0.0015	CcSEcCtD
Alprostadil—Haemoglobin—Dexamethasone—multiple sclerosis	0.000378	0.0015	CcSEcCtD
Alprostadil—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000378	0.00149	CcSEcCtD
Alprostadil—Haemorrhage—Betamethasone—multiple sclerosis	0.000376	0.00149	CcSEcCtD
Alprostadil—Haemorrhage—Dexamethasone—multiple sclerosis	0.000376	0.00149	CcSEcCtD
Alprostadil—Rash—Cladribine—multiple sclerosis	0.000375	0.00148	CcSEcCtD
Alprostadil—Dermatitis—Cladribine—multiple sclerosis	0.000374	0.00148	CcSEcCtD
Alprostadil—Headache—Cladribine—multiple sclerosis	0.000372	0.00147	CcSEcCtD
Alprostadil—Hyperglycaemia—Prednisone—multiple sclerosis	0.00037	0.00146	CcSEcCtD
Alprostadil—Hypotension—Mitoxantrone—multiple sclerosis	0.000365	0.00144	CcSEcCtD
Alprostadil—Visual impairment—Betamethasone—multiple sclerosis	0.000363	0.00143	CcSEcCtD
Alprostadil—Visual impairment—Dexamethasone—multiple sclerosis	0.000363	0.00143	CcSEcCtD
Alprostadil—Erythema—Triamcinolone—multiple sclerosis	0.000361	0.00143	CcSEcCtD
Alprostadil—Erythema—Methylprednisolone—multiple sclerosis	0.00036	0.00142	CcSEcCtD
Alprostadil—Acute coronary syndrome—Prednisone—multiple sclerosis	0.00036	0.00142	CcSEcCtD
Alprostadil—Myocardial infarction—Prednisone—multiple sclerosis	0.000358	0.00142	CcSEcCtD
Alprostadil—Nausea—Cladribine—multiple sclerosis	0.000353	0.0014	CcSEcCtD
Alprostadil—Syncope—Prednisolone—multiple sclerosis	0.000352	0.00139	CcSEcCtD
Alprostadil—Back pain—Triamcinolone—multiple sclerosis	0.000349	0.00138	CcSEcCtD
Alprostadil—Loss of consciousness—Prednisolone—multiple sclerosis	0.000345	0.00136	CcSEcCtD
Alprostadil—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000344	0.00136	CcSEcCtD
Alprostadil—Convulsion—Prednisolone—multiple sclerosis	0.00034	0.00135	CcSEcCtD
Alprostadil—Hypertension—Prednisolone—multiple sclerosis	0.000339	0.00134	CcSEcCtD
Alprostadil—Pain—Mitoxantrone—multiple sclerosis	0.000334	0.00132	CcSEcCtD
Alprostadil—Bradycardia—Prednisone—multiple sclerosis	0.000334	0.00132	CcSEcCtD
Alprostadil—Diarrhoea—Azathioprine—multiple sclerosis	0.000331	0.00131	CcSEcCtD
Alprostadil—Discomfort—Prednisolone—multiple sclerosis	0.00033	0.00131	CcSEcCtD
Alprostadil—Haemoglobin—Prednisone—multiple sclerosis	0.00033	0.0013	CcSEcCtD
Alprostadil—Haemorrhage—Prednisone—multiple sclerosis	0.000328	0.0013	CcSEcCtD
Alprostadil—Erythema—Betamethasone—multiple sclerosis	0.000328	0.0013	CcSEcCtD
Alprostadil—Erythema—Dexamethasone—multiple sclerosis	0.000328	0.0013	CcSEcCtD
Alprostadil—Syncope—Triamcinolone—multiple sclerosis	0.000324	0.00128	CcSEcCtD
Alprostadil—Syncope—Methylprednisolone—multiple sclerosis	0.000323	0.00128	CcSEcCtD
Alprostadil—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000322	0.00127	CcSEcCtD
Alprostadil—Oedema—Prednisolone—multiple sclerosis	0.000321	0.00127	CcSEcCtD
Alprostadil—Dizziness—Azathioprine—multiple sclerosis	0.00032	0.00126	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000318	0.00126	CcSEcCtD
Alprostadil—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000317	0.00125	CcSEcCtD
Alprostadil—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000317	0.00125	CcSEcCtD
Alprostadil—Shock—Prednisolone—multiple sclerosis	0.000315	0.00125	CcSEcCtD
Alprostadil—Cough—Triamcinolone—multiple sclerosis	0.000315	0.00125	CcSEcCtD
Alprostadil—Convulsion—Triamcinolone—multiple sclerosis	0.000313	0.00124	CcSEcCtD
Alprostadil—Tachycardia—Prednisolone—multiple sclerosis	0.000313	0.00124	CcSEcCtD
Alprostadil—Convulsion—Methylprednisolone—multiple sclerosis	0.000312	0.00123	CcSEcCtD
Alprostadil—Hypertension—Triamcinolone—multiple sclerosis	0.000312	0.00123	CcSEcCtD
Alprostadil—Hypertension—Methylprednisolone—multiple sclerosis	0.000311	0.00123	CcSEcCtD
Alprostadil—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00031	0.00123	CcSEcCtD
Alprostadil—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000309	0.00122	CcSEcCtD
Alprostadil—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000309	0.00122	CcSEcCtD
Alprostadil—Rash—Azathioprine—multiple sclerosis	0.000305	0.0012	CcSEcCtD
Alprostadil—Dermatitis—Azathioprine—multiple sclerosis	0.000304	0.0012	CcSEcCtD
Alprostadil—Flushing—Prednisone—multiple sclerosis	0.000304	0.0012	CcSEcCtD
Alprostadil—Discomfort—Triamcinolone—multiple sclerosis	0.000304	0.0012	CcSEcCtD
Alprostadil—Discomfort—Methylprednisolone—multiple sclerosis	0.000303	0.0012	CcSEcCtD
Alprostadil—Headache—Azathioprine—multiple sclerosis	0.000303	0.0012	CcSEcCtD
Alprostadil—Dry mouth—Triamcinolone—multiple sclerosis	0.000301	0.00119	CcSEcCtD
Alprostadil—Renal failure—Methotrexate—multiple sclerosis	0.0003	0.00119	CcSEcCtD
Alprostadil—Oedema—Triamcinolone—multiple sclerosis	0.000295	0.00117	CcSEcCtD
Alprostadil—Syncope—Betamethasone—multiple sclerosis	0.000294	0.00116	CcSEcCtD
Alprostadil—Syncope—Dexamethasone—multiple sclerosis	0.000294	0.00116	CcSEcCtD
Alprostadil—Infection—Triamcinolone—multiple sclerosis	0.000293	0.00116	CcSEcCtD
Alprostadil—Infection—Methylprednisolone—multiple sclerosis	0.000292	0.00116	CcSEcCtD
Alprostadil—Haematuria—Methotrexate—multiple sclerosis	0.000291	0.00115	CcSEcCtD
Alprostadil—Shock—Triamcinolone—multiple sclerosis	0.00029	0.00115	CcSEcCtD
Alprostadil—Shock—Methylprednisolone—multiple sclerosis	0.000289	0.00114	CcSEcCtD
Alprostadil—Loss of consciousness—Betamethasone—multiple sclerosis	0.000288	0.00114	CcSEcCtD
Alprostadil—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000288	0.00114	CcSEcCtD
Alprostadil—Tachycardia—Triamcinolone—multiple sclerosis	0.000288	0.00114	CcSEcCtD
Alprostadil—Nausea—Azathioprine—multiple sclerosis	0.000287	0.00113	CcSEcCtD
Alprostadil—Tachycardia—Methylprednisolone—multiple sclerosis	0.000287	0.00113	CcSEcCtD
Alprostadil—Skin disorder—Methylprednisolone—multiple sclerosis	0.000286	0.00113	CcSEcCtD
Alprostadil—Erythema—Prednisone—multiple sclerosis	0.000285	0.00113	CcSEcCtD
Alprostadil—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000285	0.00113	CcSEcCtD
Alprostadil—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000284	0.00112	CcSEcCtD
Alprostadil—Convulsion—Betamethasone—multiple sclerosis	0.000284	0.00112	CcSEcCtD
Alprostadil—Convulsion—Dexamethasone—multiple sclerosis	0.000284	0.00112	CcSEcCtD
Alprostadil—Hypertension—Betamethasone—multiple sclerosis	0.000283	0.00112	CcSEcCtD
Alprostadil—Hypertension—Dexamethasone—multiple sclerosis	0.000283	0.00112	CcSEcCtD
Alprostadil—Asthenia—Mitoxantrone—multiple sclerosis	0.00028	0.00111	CcSEcCtD
Alprostadil—Discomfort—Dexamethasone—multiple sclerosis	0.000276	0.00109	CcSEcCtD
Alprostadil—Discomfort—Betamethasone—multiple sclerosis	0.000276	0.00109	CcSEcCtD
Alprostadil—Haemoglobin—Methotrexate—multiple sclerosis	0.000275	0.00109	CcSEcCtD
Alprostadil—Hypotension—Methylprednisolone—multiple sclerosis	0.000275	0.00109	CcSEcCtD
Alprostadil—Pain—Prednisolone—multiple sclerosis	0.000274	0.00108	CcSEcCtD
Alprostadil—Haemorrhage—Methotrexate—multiple sclerosis	0.000274	0.00108	CcSEcCtD
Alprostadil—Pharyngitis—Methotrexate—multiple sclerosis	0.000272	0.00108	CcSEcCtD
Alprostadil—Urethral disorder—Methotrexate—multiple sclerosis	0.000269	0.00106	CcSEcCtD
Alprostadil—Oedema—Dexamethasone—multiple sclerosis	0.000267	0.00106	CcSEcCtD
Alprostadil—Oedema—Betamethasone—multiple sclerosis	0.000267	0.00106	CcSEcCtD
Alprostadil—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000267	0.00106	CcSEcCtD
Alprostadil—Infection—Dexamethasone—multiple sclerosis	0.000266	0.00105	CcSEcCtD
Alprostadil—Infection—Betamethasone—multiple sclerosis	0.000266	0.00105	CcSEcCtD
Alprostadil—Feeling abnormal—Prednisolone—multiple sclerosis	0.000264	0.00104	CcSEcCtD
Alprostadil—Visual impairment—Methotrexate—multiple sclerosis	0.000264	0.00104	CcSEcCtD
Alprostadil—Anaemia—Prednisone—multiple sclerosis	0.000264	0.00104	CcSEcCtD
Alprostadil—Shock—Dexamethasone—multiple sclerosis	0.000263	0.00104	CcSEcCtD
Alprostadil—Shock—Betamethasone—multiple sclerosis	0.000263	0.00104	CcSEcCtD
Alprostadil—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000262	0.00104	CcSEcCtD
Alprostadil—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000262	0.00104	CcSEcCtD
Alprostadil—Tachycardia—Dexamethasone—multiple sclerosis	0.000261	0.00103	CcSEcCtD
Alprostadil—Tachycardia—Betamethasone—multiple sclerosis	0.000261	0.00103	CcSEcCtD
Alprostadil—Dyspepsia—Triamcinolone—multiple sclerosis	0.000259	0.00103	CcSEcCtD
Alprostadil—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000259	0.00102	CcSEcCtD
Alprostadil—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000259	0.00102	CcSEcCtD
Alprostadil—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000259	0.00102	CcSEcCtD
Alprostadil—Syncope—Prednisone—multiple sclerosis	0.000256	0.00101	CcSEcCtD
Alprostadil—Pain—Triamcinolone—multiple sclerosis	0.000252	0.000997	CcSEcCtD
Alprostadil—Loss of consciousness—Prednisone—multiple sclerosis	0.000251	0.000992	CcSEcCtD
Alprostadil—Hypotension—Dexamethasone—multiple sclerosis	0.00025	0.000988	CcSEcCtD
Alprostadil—Hypotension—Betamethasone—multiple sclerosis	0.00025	0.000988	CcSEcCtD
Alprostadil—Convulsion—Prednisone—multiple sclerosis	0.000247	0.000978	CcSEcCtD
Alprostadil—Hypertension—Prednisone—multiple sclerosis	0.000246	0.000974	CcSEcCtD
Alprostadil—Rash—Mitoxantrone—multiple sclerosis	0.000246	0.000974	CcSEcCtD
Alprostadil—Dermatitis—Mitoxantrone—multiple sclerosis	0.000246	0.000973	CcSEcCtD
Alprostadil—Headache—Mitoxantrone—multiple sclerosis	0.000245	0.000968	CcSEcCtD
Alprostadil—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000243	0.00096	CcSEcCtD
Alprostadil—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000242	0.000958	CcSEcCtD
Alprostadil—Discomfort—Prednisone—multiple sclerosis	0.00024	0.000949	CcSEcCtD
Alprostadil—Erythema—Methotrexate—multiple sclerosis	0.000239	0.000943	CcSEcCtD
Alprostadil—Dyspepsia—Dexamethasone—multiple sclerosis	0.000235	0.000931	CcSEcCtD
Alprostadil—Dyspepsia—Betamethasone—multiple sclerosis	0.000235	0.000931	CcSEcCtD
Alprostadil—ABCC4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000234	0.000965	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—LINGO1—multiple sclerosis	0.000234	0.000965	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—LINGO1—multiple sclerosis	0.000234	0.000965	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CCL3—multiple sclerosis	0.000233	0.000962	CbGpPWpGaD
Alprostadil—Body temperature increased—Triamcinolone—multiple sclerosis	0.000233	0.000921	CcSEcCtD
Alprostadil—Oedema—Prednisone—multiple sclerosis	0.000233	0.000921	CcSEcCtD
Alprostadil—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000233	0.000919	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—CCR2—multiple sclerosis	0.000232	0.000958	CbGpPWpGaD
Alprostadil—Nausea—Mitoxantrone—multiple sclerosis	0.000232	0.000917	CcSEcCtD
Alprostadil—Infection—Prednisone—multiple sclerosis	0.000231	0.000915	CcSEcCtD
Alprostadil—PTGIR—Hemostasis—ITGA4—multiple sclerosis	0.000231	0.000952	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CXCL10—multiple sclerosis	0.000231	0.000952	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000231	0.000952	CbGpPWpGaD
Alprostadil—Back pain—Methotrexate—multiple sclerosis	0.000231	0.000912	CcSEcCtD
Alprostadil—PTGIR—Hemostasis—IFNB1—multiple sclerosis	0.000229	0.000945	CbGpPWpGaD
Alprostadil—Shock—Prednisone—multiple sclerosis	0.000229	0.000906	CcSEcCtD
Alprostadil—Pain—Dexamethasone—multiple sclerosis	0.000229	0.000904	CcSEcCtD
Alprostadil—Pain—Betamethasone—multiple sclerosis	0.000229	0.000904	CcSEcCtD
Alprostadil—Tachycardia—Prednisone—multiple sclerosis	0.000227	0.000899	CcSEcCtD
Alprostadil—Skin disorder—Prednisone—multiple sclerosis	0.000226	0.000894	CcSEcCtD
Alprostadil—Hyperhidrosis—Prednisone—multiple sclerosis	0.000225	0.00089	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—PTGER4—multiple sclerosis	0.000225	0.000926	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—RGS1—multiple sclerosis	0.000223	0.00092	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCR1—multiple sclerosis	0.000221	0.000912	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CXCL13—multiple sclerosis	0.000221	0.000912	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000221	0.000912	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CCR1—multiple sclerosis	0.000221	0.000912	CbGpPWpGaD
Alprostadil—Anaemia—Methotrexate—multiple sclerosis	0.00022	0.000872	CcSEcCtD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.00022	0.000909	CbGpPWpGaD
Alprostadil—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00022	0.000871	CcSEcCtD
Alprostadil—Feeling abnormal—Betamethasone—multiple sclerosis	0.00022	0.000871	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—CXCR3—multiple sclerosis	0.000217	0.000895	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—CNR1—multiple sclerosis	0.000214	0.000884	CbGpPWpGaD
Alprostadil—Dizziness—Prednisolone—multiple sclerosis	0.000212	0.000838	CcSEcCtD
Alprostadil—ABCC5—Disease—GPC5—multiple sclerosis	0.000212	0.000873	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—GPR65—multiple sclerosis	0.000212	0.000872	CbGpPWpGaD
Alprostadil—Asthenia—Triamcinolone—multiple sclerosis	0.000212	0.000836	CcSEcCtD
Alprostadil—Body temperature increased—Dexamethasone—multiple sclerosis	0.000211	0.000836	CcSEcCtD
Alprostadil—Body temperature increased—Betamethasone—multiple sclerosis	0.000211	0.000836	CcSEcCtD
Alprostadil—Abdominal pain—Dexamethasone—multiple sclerosis	0.000211	0.000836	CcSEcCtD
Alprostadil—Abdominal pain—Betamethasone—multiple sclerosis	0.000211	0.000836	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—CCR2—multiple sclerosis	0.000211	0.00087	CbGpPWpGaD
Alprostadil—Asthenia—Methylprednisolone—multiple sclerosis	0.000211	0.000834	CcSEcCtD
Alprostadil—Pruritus—Triamcinolone—multiple sclerosis	0.000209	0.000824	CcSEcCtD
Alprostadil—Cough—Methotrexate—multiple sclerosis	0.000208	0.000823	CcSEcCtD
Alprostadil—Pruritus—Methylprednisolone—multiple sclerosis	0.000208	0.000823	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—POMC—multiple sclerosis	0.000207	0.000854	CbGpPWpGaD
Alprostadil—Convulsion—Methotrexate—multiple sclerosis	0.000207	0.000817	CcSEcCtD
Alprostadil—ABCC4—Ectoderm Differentiation—CCL2—multiple sclerosis	0.000206	0.000851	CbGpPWpGaD
Alprostadil—Dyspepsia—Prednisone—multiple sclerosis	0.000205	0.000811	CcSEcCtD
Alprostadil—PTGIR—Signaling Pathways—TAGAP—multiple sclerosis	0.000203	0.000836	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TAGAP—multiple sclerosis	0.000203	0.000836	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—CCL2—multiple sclerosis	0.000203	0.000836	CbGpPWpGaD
Alprostadil—Rash—Prednisolone—multiple sclerosis	0.000202	0.000799	CcSEcCtD
Alprostadil—Dermatitis—Prednisolone—multiple sclerosis	0.000202	0.000798	CcSEcCtD
Alprostadil—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000201	0.000796	CcSEcCtD
Alprostadil—Headache—Prednisolone—multiple sclerosis	0.000201	0.000794	CcSEcCtD
Alprostadil—Discomfort—Methotrexate—multiple sclerosis	0.000201	0.000793	CcSEcCtD
Alprostadil—PTGIR—GPCR ligand binding—CCL5—multiple sclerosis	0.000199	0.000819	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—CCL5—multiple sclerosis	0.000199	0.000819	CbGpPWpGaD
Alprostadil—Dizziness—Triamcinolone—multiple sclerosis	0.000195	0.000771	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—CNR1—multiple sclerosis	0.000195	0.000803	CbGpPWpGaD
Alprostadil—Dizziness—Methylprednisolone—multiple sclerosis	0.000195	0.000769	CcSEcCtD
Alprostadil—ABCC5—Metabolism—CYP27B1—multiple sclerosis	0.000194	0.0008	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CYP24A1—multiple sclerosis	0.000194	0.0008	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCR1—multiple sclerosis	0.000193	0.000798	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CXCL13—multiple sclerosis	0.000193	0.000798	CbGpPWpGaD
Alprostadil—Infection—Methotrexate—multiple sclerosis	0.000193	0.000765	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000193	0.000796	CbGpPWpGaD
Alprostadil—Feeling abnormal—Prednisone—multiple sclerosis	0.000192	0.000759	CcSEcCtD
Alprostadil—Asthenia—Dexamethasone—multiple sclerosis	0.000192	0.000759	CcSEcCtD
Alprostadil—Asthenia—Betamethasone—multiple sclerosis	0.000192	0.000759	CcSEcCtD
Alprostadil—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000191	0.000753	CcSEcCtD
Alprostadil—Nausea—Prednisolone—multiple sclerosis	0.00019	0.000753	CcSEcCtD
Alprostadil—ABCC4—Hemostasis—SELE—multiple sclerosis	0.00019	0.000785	CbGpPWpGaD
Alprostadil—Pruritus—Dexamethasone—multiple sclerosis	0.000189	0.000748	CcSEcCtD
Alprostadil—Pruritus—Betamethasone—multiple sclerosis	0.000189	0.000748	CcSEcCtD
Alprostadil—Skin disorder—Methotrexate—multiple sclerosis	0.000189	0.000747	CcSEcCtD
Alprostadil—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000188	0.000744	CcSEcCtD
Alprostadil—ABCC4—Platelet degranulation—TGFB1—multiple sclerosis	0.000188	0.000776	CbGpPWpGaD
Alprostadil—Rash—Triamcinolone—multiple sclerosis	0.000186	0.000735	CcSEcCtD
Alprostadil—Dermatitis—Triamcinolone—multiple sclerosis	0.000186	0.000734	CcSEcCtD
Alprostadil—Rash—Methylprednisolone—multiple sclerosis	0.000185	0.000733	CcSEcCtD
Alprostadil—Dermatitis—Methylprednisolone—multiple sclerosis	0.000185	0.000732	CcSEcCtD
Alprostadil—ABCC4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000185	0.000763	CbGpPWpGaD
Alprostadil—Headache—Triamcinolone—multiple sclerosis	0.000185	0.00073	CcSEcCtD
Alprostadil—Headache—Methylprednisolone—multiple sclerosis	0.000184	0.000728	CcSEcCtD
Alprostadil—Abdominal pain—Prednisone—multiple sclerosis	0.000184	0.000728	CcSEcCtD
Alprostadil—Body temperature increased—Prednisone—multiple sclerosis	0.000184	0.000728	CcSEcCtD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000184	0.000758	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000184	0.000758	CbGpPWpGaD
Alprostadil—Diarrhoea—Dexamethasone—multiple sclerosis	0.000183	0.000723	CcSEcCtD
Alprostadil—Diarrhoea—Betamethasone—multiple sclerosis	0.000183	0.000723	CcSEcCtD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	0.000182	0.000752	CbGpPWpGaD
Alprostadil—Hypotension—Methotrexate—multiple sclerosis	0.000182	0.000719	CcSEcCtD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00018	0.000741	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00018	0.000741	CbGpPWpGaD
Alprostadil—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	0.000179	0.000739	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—CCR5—multiple sclerosis	0.000179	0.000738	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CCR5—multiple sclerosis	0.000179	0.000738	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GPC5—multiple sclerosis	0.000177	0.000731	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—S1PR1—multiple sclerosis	0.000177	0.000731	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—S1PR1—multiple sclerosis	0.000177	0.000731	CbGpPWpGaD
Alprostadil—Dizziness—Betamethasone—multiple sclerosis	0.000177	0.000699	CcSEcCtD
Alprostadil—Dizziness—Dexamethasone—multiple sclerosis	0.000177	0.000699	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—CXCL10—multiple sclerosis	0.000175	0.000723	CbGpPWpGaD
Alprostadil—Nausea—Triamcinolone—multiple sclerosis	0.000175	0.000692	CcSEcCtD
Alprostadil—SLCO2B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000175	0.000721	CbGpPWpGaD
Alprostadil—Nausea—Methylprednisolone—multiple sclerosis	0.000175	0.000691	CcSEcCtD
Alprostadil—PTGER1—Signaling Pathways—GPC5—multiple sclerosis	0.000172	0.000711	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GPC5—multiple sclerosis	0.000172	0.000711	CbGpPWpGaD
Alprostadil—Dyspepsia—Methotrexate—multiple sclerosis	0.000171	0.000677	CcSEcCtD
Alprostadil—Rash—Betamethasone—multiple sclerosis	0.000169	0.000667	CcSEcCtD
Alprostadil—Rash—Dexamethasone—multiple sclerosis	0.000169	0.000667	CcSEcCtD
Alprostadil—Dermatitis—Betamethasone—multiple sclerosis	0.000168	0.000666	CcSEcCtD
Alprostadil—Dermatitis—Dexamethasone—multiple sclerosis	0.000168	0.000666	CcSEcCtD
Alprostadil—ABCC5—NRF2 pathway—TGFB1—multiple sclerosis	0.000168	0.000691	CbGpPWpGaD
Alprostadil—Headache—Betamethasone—multiple sclerosis	0.000168	0.000662	CcSEcCtD
Alprostadil—Headache—Dexamethasone—multiple sclerosis	0.000168	0.000662	CcSEcCtD
Alprostadil—Asthenia—Prednisone—multiple sclerosis	0.000167	0.000661	CcSEcCtD
Alprostadil—PTGIR—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000167	0.000689	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000167	0.000689	CbGpPWpGaD
Alprostadil—Pain—Methotrexate—multiple sclerosis	0.000166	0.000658	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—CCL5—multiple sclerosis	0.000166	0.000686	CbGpPWpGaD
Alprostadil—Pruritus—Prednisone—multiple sclerosis	0.000165	0.000651	CcSEcCtD
Alprostadil—ABCC4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000163	0.000674	CbGpPWpGaD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000162	0.000667	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000161	0.000665	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000161	0.000665	CbGpPWpGaD
Alprostadil—Feeling abnormal—Methotrexate—multiple sclerosis	0.00016	0.000634	CcSEcCtD
Alprostadil—Diarrhoea—Prednisone—multiple sclerosis	0.000159	0.00063	CcSEcCtD
Alprostadil—Nausea—Dexamethasone—multiple sclerosis	0.000159	0.000628	CcSEcCtD
Alprostadil—Nausea—Betamethasone—multiple sclerosis	0.000159	0.000628	CcSEcCtD
Alprostadil—PTGIR—Hemostasis—IL2RA—multiple sclerosis	0.000158	0.000651	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCL3—multiple sclerosis	0.000158	0.00065	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CCL3—multiple sclerosis	0.000158	0.00065	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CCR2—multiple sclerosis	0.000157	0.000647	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000157	0.000647	CbGpPWpGaD
Alprostadil—Dizziness—Prednisone—multiple sclerosis	0.000154	0.000609	CcSEcCtD
Alprostadil—Abdominal pain—Methotrexate—multiple sclerosis	0.000154	0.000608	CcSEcCtD
Alprostadil—Body temperature increased—Methotrexate—multiple sclerosis	0.000154	0.000608	CcSEcCtD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000153	0.000632	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000152	0.000626	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PTGER4—multiple sclerosis	0.000152	0.000626	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CCL5—multiple sclerosis	0.000151	0.000623	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—RGS1—multiple sclerosis	0.000151	0.000622	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RGS1—multiple sclerosis	0.000151	0.000622	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—CCR5—multiple sclerosis	0.00015	0.000618	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000148	0.000609	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—RRM1—multiple sclerosis	0.000147	0.000606	CbGpPWpGaD
Alprostadil—Rash—Prednisone—multiple sclerosis	0.000147	0.000581	CcSEcCtD
Alprostadil—Dermatitis—Prednisone—multiple sclerosis	0.000147	0.00058	CcSEcCtD
Alprostadil—PTGER1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000147	0.000604	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CXCR3—multiple sclerosis	0.000147	0.000604	CbGpPWpGaD
Alprostadil—Headache—Prednisone—multiple sclerosis	0.000146	0.000577	CcSEcCtD
Alprostadil—PTGIR—GPCR downstream signaling—CNR1—multiple sclerosis	0.000145	0.000597	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000145	0.000597	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GPR65—multiple sclerosis	0.000143	0.000589	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GPR65—multiple sclerosis	0.000143	0.000589	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCR2—multiple sclerosis	0.000143	0.000588	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CCR2—multiple sclerosis	0.000143	0.000588	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.00014	0.000579	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—POMC—multiple sclerosis	0.00014	0.000577	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—POMC—multiple sclerosis	0.00014	0.000577	CbGpPWpGaD
Alprostadil—Asthenia—Methotrexate—multiple sclerosis	0.00014	0.000552	CcSEcCtD
Alprostadil—Nausea—Prednisone—multiple sclerosis	0.000138	0.000547	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—CCL3—multiple sclerosis	0.000138	0.000568	CbGpPWpGaD
Alprostadil—Pruritus—Methotrexate—multiple sclerosis	0.000138	0.000544	CcSEcCtD
Alprostadil—ABCC5—Disease—RPL5—multiple sclerosis	0.000138	0.000568	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—ITGA4—multiple sclerosis	0.000138	0.000568	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CCL2—multiple sclerosis	0.000137	0.000564	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—CCL2—multiple sclerosis	0.000137	0.000564	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IFNB1—multiple sclerosis	0.000137	0.000563	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CCR5—multiple sclerosis	0.000136	0.000561	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL2RA—multiple sclerosis	0.000134	0.000553	CbGpPWpGaD
Alprostadil—Diarrhoea—Methotrexate—multiple sclerosis	0.000133	0.000527	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—PTGER4—multiple sclerosis	0.000133	0.000547	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	0.000132	0.000544	CbGpPWpGaD
Alprostadil—ABCC5—Disease—SLC11A1—multiple sclerosis	0.000132	0.000544	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CNR1—multiple sclerosis	0.000132	0.000543	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CNR1—multiple sclerosis	0.000132	0.000543	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCR1—multiple sclerosis	0.000131	0.000539	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CXCL13—multiple sclerosis	0.000131	0.000539	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CXCL13—multiple sclerosis	0.000131	0.000539	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCR1—multiple sclerosis	0.000131	0.000539	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PGR—multiple sclerosis	0.000131	0.000539	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00013	0.000538	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00013	0.000538	CbGpPWpGaD
Alprostadil—Dizziness—Methotrexate—multiple sclerosis	0.000129	0.000509	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—CXCR3—multiple sclerosis	0.000128	0.000529	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CD28—multiple sclerosis	0.000127	0.000524	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCR2—multiple sclerosis	0.000125	0.000514	CbGpPWpGaD
Alprostadil—Rash—Methotrexate—multiple sclerosis	0.000123	0.000485	CcSEcCtD
Alprostadil—Dermatitis—Methotrexate—multiple sclerosis	0.000123	0.000485	CcSEcCtD
Alprostadil—Headache—Methotrexate—multiple sclerosis	0.000122	0.000482	CcSEcCtD
Alprostadil—ABCC4—Ectoderm Differentiation—MYC—multiple sclerosis	0.000122	0.000503	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CXCL10—multiple sclerosis	0.000118	0.000488	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000118	0.000488	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—POMC—multiple sclerosis	0.000117	0.000483	CbGpPWpGaD
Alprostadil—ABCC4—NRF2 pathway—TGFB1—multiple sclerosis	0.000116	0.000479	CbGpPWpGaD
Alprostadil—Nausea—Methotrexate—multiple sclerosis	0.000116	0.000457	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—CNR1—multiple sclerosis	0.000115	0.000474	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—ALB—multiple sclerosis	0.000114	0.00047	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CCL5—multiple sclerosis	0.000112	0.000463	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000112	0.000463	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000108	0.000445	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.000107	0.000441	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—POMC—multiple sclerosis	0.000106	0.000438	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CD28—multiple sclerosis	0.000105	0.000434	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CCL2—multiple sclerosis	0.000104	0.000429	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CXCL10—multiple sclerosis	0.000104	0.000427	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CCL5—multiple sclerosis	0.000102	0.00042	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCL5—multiple sclerosis	0.000102	0.00042	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CCR5—multiple sclerosis	0.000101	0.000417	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000101	0.000417	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—IL2RA—multiple sclerosis	9.97e-05	0.000411	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—IL2RA—multiple sclerosis	9.97e-05	0.000411	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—TYK2—multiple sclerosis	9.44e-05	0.000389	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IL2RA—multiple sclerosis	9.4e-05	0.000388	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCL3—multiple sclerosis	9.31e-05	0.000384	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCL3—multiple sclerosis	9.31e-05	0.000384	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—IL2—multiple sclerosis	9.25e-05	0.000381	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CCR5—multiple sclerosis	9.19e-05	0.000379	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCR5—multiple sclerosis	9.19e-05	0.000379	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CD86—multiple sclerosis	9.06e-05	0.000374	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL2RA—multiple sclerosis	9.05e-05	0.000373	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL2RA—multiple sclerosis	9.05e-05	0.000373	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PTGER4—multiple sclerosis	8.96e-05	0.00037	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PTGER4—multiple sclerosis	8.96e-05	0.00037	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCL5—multiple sclerosis	8.92e-05	0.000368	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.88e-05	0.000366	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PGR—multiple sclerosis	8.83e-05	0.000364	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PGR—multiple sclerosis	8.83e-05	0.000364	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CXCR3—multiple sclerosis	8.66e-05	0.000357	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CXCR3—multiple sclerosis	8.66e-05	0.000357	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—IL2—multiple sclerosis	8.65e-05	0.000357	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CD28—multiple sclerosis	8.58e-05	0.000354	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CD28—multiple sclerosis	8.58e-05	0.000354	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.49e-05	0.00035	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—BCHE—multiple sclerosis	8.44e-05	0.000348	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCR2—multiple sclerosis	8.42e-05	0.000347	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCR2—multiple sclerosis	8.42e-05	0.000347	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	8.34e-05	0.000344	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SPP1—multiple sclerosis	8.26e-05	0.000341	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	8.18e-05	0.000337	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCR5—multiple sclerosis	8.03e-05	0.000331	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL2RA—multiple sclerosis	7.92e-05	0.000327	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—POMC—multiple sclerosis	7.91e-05	0.000326	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—POMC—multiple sclerosis	7.91e-05	0.000326	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL2—multiple sclerosis	7.86e-05	0.000324	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CNR1—multiple sclerosis	7.77e-05	0.00032	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CNR1—multiple sclerosis	7.77e-05	0.00032	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CD86—multiple sclerosis	7.51e-05	0.00031	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—APOE—multiple sclerosis	7.31e-05	0.000301	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—TGFB1—multiple sclerosis	7.21e-05	0.000297	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—POMC—multiple sclerosis	7.18e-05	0.000296	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—POMC—multiple sclerosis	7.18e-05	0.000296	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—MAPK1—multiple sclerosis	7.08e-05	0.000292	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCL2—multiple sclerosis	7.03e-05	0.00029	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CCL2—multiple sclerosis	7.03e-05	0.00029	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CXCL10—multiple sclerosis	7e-05	0.000289	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CXCL10—multiple sclerosis	7e-05	0.000289	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—ALB—multiple sclerosis	6.8e-05	0.00028	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CCR5—multiple sclerosis	6.66e-05	0.000275	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CD80—multiple sclerosis	6.61e-05	0.000273	CbGpPWpGaD
Alprostadil—ABCC5—Disease—HLA-A—multiple sclerosis	6.49e-05	0.000268	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—TYK2—multiple sclerosis	6.38e-05	0.000263	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—TYK2—multiple sclerosis	6.38e-05	0.000263	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—POMC—multiple sclerosis	6.28e-05	0.000259	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCL2—multiple sclerosis	6.14e-05	0.000253	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CD86—multiple sclerosis	6.12e-05	0.000252	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CD86—multiple sclerosis	6.12e-05	0.000252	CbGpPWpGaD
Alprostadil—ABCC5—Disease—APOE—multiple sclerosis	6.06e-05	0.00025	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCL5—multiple sclerosis	6.02e-05	0.000248	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCL5—multiple sclerosis	6.02e-05	0.000248	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—MAPK1—multiple sclerosis	6.01e-05	0.000248	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.89e-05	0.000243	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—IL2—multiple sclerosis	5.85e-05	0.000241	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—IL2—multiple sclerosis	5.85e-05	0.000241	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TYK2—multiple sclerosis	5.58e-05	0.00023	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SPP1—multiple sclerosis	5.58e-05	0.00023	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SPP1—multiple sclerosis	5.58e-05	0.00023	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IL2—multiple sclerosis	5.51e-05	0.000227	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CD80—multiple sclerosis	5.48e-05	0.000226	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCR5—multiple sclerosis	5.43e-05	0.000224	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCR5—multiple sclerosis	5.43e-05	0.000224	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL2RA—multiple sclerosis	5.35e-05	0.000221	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL2RA—multiple sclerosis	5.35e-05	0.000221	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL2—multiple sclerosis	5.31e-05	0.000219	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL2—multiple sclerosis	5.31e-05	0.000219	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—APOE—multiple sclerosis	5.08e-05	0.000209	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—APOE—multiple sclerosis	4.94e-05	0.000204	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—APOE—multiple sclerosis	4.94e-05	0.000204	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL2—multiple sclerosis	4.64e-05	0.000191	CbGpPWpGaD
Alprostadil—ABCC5—Disease—TYK2—multiple sclerosis	4.63e-05	0.000191	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL6—multiple sclerosis	4.62e-05	0.00019	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CD80—multiple sclerosis	4.46e-05	0.000184	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CD80—multiple sclerosis	4.46e-05	0.000184	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MMP9—multiple sclerosis	4.39e-05	0.000181	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—POMC—multiple sclerosis	4.36e-05	0.00018	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—TGFB1—multiple sclerosis	4.3e-05	0.000177	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—POMC—multiple sclerosis	4.24e-05	0.000175	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—POMC—multiple sclerosis	4.24e-05	0.000175	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—MAPK1—multiple sclerosis	4.22e-05	0.000174	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CD4—multiple sclerosis	4.19e-05	0.000173	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCL2—multiple sclerosis	4.15e-05	0.000171	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCL2—multiple sclerosis	4.15e-05	0.000171	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—MAPK1—multiple sclerosis	4.06e-05	0.000167	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—MAPK1—multiple sclerosis	4.06e-05	0.000167	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ALB—multiple sclerosis	3.98e-05	0.000164	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—STAT3—multiple sclerosis	3.91e-05	0.000161	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TYK2—multiple sclerosis	3.77e-05	0.000155	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TYK2—multiple sclerosis	3.77e-05	0.000155	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MYC—multiple sclerosis	3.63e-05	0.00015	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TGFB1—multiple sclerosis	3.62e-05	0.000149	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MAPK1—multiple sclerosis	3.55e-05	0.000146	CbGpPWpGaD
Alprostadil—ABCC5—Disease—STAT3—multiple sclerosis	3.24e-05	0.000134	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL2—multiple sclerosis	3.14e-05	0.000129	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL2—multiple sclerosis	3.14e-05	0.000129	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL6—multiple sclerosis	3.12e-05	0.000129	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL6—multiple sclerosis	3.12e-05	0.000129	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MYC—multiple sclerosis	3.01e-05	0.000124	CbGpPWpGaD
Alprostadil—ABCC5—Disease—TGFB1—multiple sclerosis	3e-05	0.000124	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MMP9—multiple sclerosis	2.97e-05	0.000122	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MMP9—multiple sclerosis	2.97e-05	0.000122	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MAPK1—multiple sclerosis	2.95e-05	0.000121	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL6—multiple sclerosis	2.73e-05	0.000113	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—STAT3—multiple sclerosis	2.64e-05	0.000109	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—STAT3—multiple sclerosis	2.64e-05	0.000109	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MYC—multiple sclerosis	2.45e-05	0.000101	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MYC—multiple sclerosis	2.45e-05	0.000101	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TGFB1—multiple sclerosis	2.45e-05	0.000101	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TGFB1—multiple sclerosis	2.45e-05	0.000101	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MAPK1—multiple sclerosis	2.4e-05	9.89e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MAPK1—multiple sclerosis	2.4e-05	9.89e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IL6—multiple sclerosis	2.26e-05	9.33e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL6—multiple sclerosis	1.84e-05	7.6e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL6—multiple sclerosis	1.84e-05	7.6e-05	CbGpPWpGaD
